RAB27A is a small GTPase belonging to the Rab family of proteins involved in vesicular trafficking. It plays a critical role in regulated secretion, particularly in neuroendocrine cells, immune cells, and melanocytes. Mutations in RAB27A cause Griscelli syndrome, a rare autosomal recessive disorder characterized by partial albinism, immunodeficiency, and neurological abnormalities.
:: infobox .infobox-protein
| RAB27A Protein |
|
| Gene |
RAB27A |
| UniProt |
P51159 |
| Molecular Weight |
~25 kDa |
| Subcellular Localization |
Cytoplasmic, associated with secretory granules |
| Protein Family |
Rab GTPase family |
| Aliases |
Rab27A, GS2 |
===
RAB27A is a member of the Rab GTPase family with characteristic features:
- GTP-binding domain: Five conserved motifs for nucleotide binding
- Switch I and II regions: Conformational changes upon GTP/GDP exchange
- C-terminal CAAX motif: Cysteine methylation and prenylation for membrane anchoring
- Hypervariable region: Determines effector specificity
- Prenylation: C-terminal cysteine prenylation for membrane association
- Palmitoylation: Additional lipid modification
- GDP/GTP cycling: Active (GTP-bound) and inactive (GDP-bound) states
RAB27A regulates vesicle trafficking through:
- Secretory granule exocytosis: Controls regulated secretion in neuroendocrine cells
- Lysosome-related organelle trafficking: Functions in melanosomes, lytic granules
- Synaptic vesicle dynamics: Involved in neurotransmitter release
- Autophagosome-lysosome fusion: Role in autophagy
RAB27A interacts with multiple effector proteins:
- Slac2-a/MyRIP: Links RAB27A to actin filaments
- Munc13-4: Regulates dense-core vesicle exocytosis
- JFC1/Slp1: Scaffold protein for exocytosis
- Synaptotagmin-like proteins: Calcium sensors for exocytosis
- Neuroendocrine cells (chromaffin cells, PC12 cells)
- Immune cells (T cells, NK cells, mast cells)
- Melanocytes
- Neurons (synaptic terminals)
- Platelets
RAB27A mutations cause Griscelli syndrome type 2:
- Clinical features:
- Partial albinism (silver-gray hair, pigmentary dilution)
- Immunodeficiency (impaired T cell and NK cell function)
- Hemophagocytic lymphohistiocytosis (HLH)
- Neurologic abnormalities (in some patients)
- Pathogenesis: Impaired secretory granule trafficking
- Inheritance: Autosomal recessive
RAB27A is essential for immune cell function:
- Cytotoxic T cells: Impaired granule release
- NK cells: Defective cytotoxicity
- Mast cells: Altered degranulation
- Platelets: Defective dense granule release
Emerging evidence for RAB27A in neurodegeneration:
RAB27A is overexpressed in several cancers:
- Melanoma: Promotes metastasis
- Pancreatic cancer: Associated with poor prognosis
- Breast cancer: Regulates exosome secretion
| Approach |
Description |
Status |
| Gene therapy |
AAV-RAB27A for GS2 |
Research |
| Small molecule modulators |
GTPase activators/inhibitors |
Research |
| Immunomodulation |
For HLH management |
Clinical |
- Display hypopigmentation
- Show immunodeficiency
- Impaired platelet function
- Neurological deficits
- Morpholino knockdown recapitulates GS2 phenotype
- Used for drug screening
RAB27A interacts with:
- GTP/GDP exchange factors (GEFs): Activate RAB27A
- GTPase activating proteins (GAPs): Inactivate RAB27A
- Effectors: Slac2-a, Munc13-4, JFC1
- Motor proteins: Myosin Va for transport